X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (19346) 19346
Book Chapter (360) 360
Newsletter (126) 126
Magazine Article (27) 27
Newspaper Article (25) 25
Book / eBook (15) 15
Dissertation (6) 6
Conference Proceeding (4) 4
Publication (3) 3
Reference (2) 2
Transcript (2) 2
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (17214) 17214
science & technology (14846) 14846
life sciences & biomedicine (14642) 14642
female (11458) 11458
oncology (10313) 10313
middle aged (10096) 10096
radiotherapy (9995) 9995
male (9390) 9390
aged (8876) 8876
adult (7469) 7469
cancer (5875) 5875
treatment outcome (5574) 5574
care and treatment (4853) 4853
surgery (4581) 4581
chemotherapy (4241) 4241
combined modality therapy (3909) 3909
aged, 80 and over (3701) 3701
radiation therapy (3690) 3690
retrospective studies (3678) 3678
neoplasm staging (3542) 3542
radiotherapy, adjuvant (3335) 3335
radiology, nuclear medicine & medical imaging (3093) 3093
medicine & public health (2994) 2994
radiation (2854) 2854
follow-up studies (2853) 2853
radiotherapy dosage (2821) 2821
hematology, oncology and palliative medicine (2694) 2694
antineoplastic combined chemotherapy protocols - therapeutic use (2475) 2475
research (2458) 2458
prognosis (2457) 2457
chemotherapy, adjuvant (2444) 2444
disease-free survival (2417) 2417
risk factors (2355) 2355
breast cancer (2265) 2265
breast neoplasms - radiotherapy (2261) 2261
radiotherapy, adjuvant - adverse effects (2184) 2184
health aspects (2176) 2176
patients (2159) 2159
radiotherapy - adverse effects (2114) 2114
analysis (2097) 2097
survival rate (1991) 1991
survival analysis (1827) 1827
time factors (1662) 1662
radiology (1578) 1578
prospective studies (1570) 1570
cancer therapies (1561) 1561
adolescent (1539) 1539
antineoplastic combined chemotherapy protocols - adverse effects (1536) 1536
prostate cancer (1523) 1523
metastasis (1497) 1497
toxicity (1489) 1489
breast neoplasms - surgery (1488) 1488
abridged index medicus (1481) 1481
tumors (1428) 1428
prostatic neoplasms - radiotherapy (1316) 1316
young adult (1314) 1314
quality of life (1312) 1312
antineoplastic agents - therapeutic use (1219) 1219
breast neoplasms - pathology (1189) 1189
patient outcomes (1185) 1185
clinical trials (1072) 1072
survival (1047) 1047
child (1046) 1046
radiology and nuclear medicine (1034) 1034
oncology, experimental (1032) 1032
carcinoma, squamous cell - radiotherapy (1010) 1010
nuclear radiation (1009) 1009
kaplan-meier estimate (1008) 1008
usage (977) 977
dose fractionation (970) 970
multivariate analysis (963) 963
radiation injuries - etiology (951) 951
cancer patients (944) 944
cisplatin - administration & dosage (940) 940
antineoplastic agents - adverse effects (939) 939
fluorouracil - administration & dosage (896) 896
brain neoplasms - radiotherapy (892) 892
neoplasm recurrence, local (869) 869
neoadjuvant therapy (849) 849
neurosciences & neurology (841) 841
risk assessment (830) 830
clinical neurology (808) 808
brachytherapy (807) 807
neoplasms (799) 799
lymphatic metastasis (796) 796
head and neck neoplasms - radiotherapy (795) 795
adenocarcinoma - radiotherapy (777) 777
medicine (770) 770
chemoradiotherapy (769) 769
diagnosis (768) 768
neoplasms. tumors. oncology. including cancer and carcinogens (755) 755
surgical oncology (730) 730
medical research (721) 721
radiotherapy, adjuvant - methods (717) 717
urology & nephrology (711) 711
radiotherapy, intensity-modulated - adverse effects (710) 710
rectal neoplasms - radiotherapy (706) 706
adjuvant treatment (696) 696
brachytherapy - methods (692) 692
mastectomy (685) 685
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (19279) 19279
German (255) 255
French (224) 224
Russian (90) 90
Japanese (80) 80
Spanish (55) 55
Hungarian (44) 44
Polish (43) 43
Chinese (31) 31
Italian (29) 29
Portuguese (26) 26
Danish (6) 6
Turkish (6) 6
Czech (5) 5
Dutch (5) 5
Romanian (5) 5
Norwegian (4) 4
Hebrew (3) 3
Icelandic (2) 2
Korean (2) 2
Serbian (2) 2
Arabic (1) 1
Bulgarian (1) 1
Finnish (1) 1
Lithuanian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 01/2015, Volume 372, Issue 5, pp. 436 - 446
Journal Article
The New England journal of medicine, ISSN 1533-4406, 07/2014, Volume 371, Issue 2, pp. 107 - 118
Journal Article
The New England journal of medicine, ISSN 1533-4406, 03/2005, Volume 352, Issue 10, pp. 987 - 996
Journal Article
The New England journal of medicine, ISSN 1533-4406, 01/2015, Volume 372, Issue 2, pp. 134 - 141
A multicenter single-group trial suggests that adjuvant therapy with paclitaxel plus trastuzumab lowers the risk of relapse in women with small HER2-positive breast cancers... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Follow-Up Studies | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Breast Neoplasms - therapy | Breast Neoplasms - chemistry | Antibodies, Monoclonal, Humanized - administration & dosage | Mastectomy, Segmental | Aged, 80 and over | Adult | Female | Receptor, ErbB-2 - immunology | Chemotherapy, Adjuvant | Paclitaxel - administration & dosage | Adenocarcinoma - chemistry | Antibodies, Monoclonal, Humanized - adverse effects | Neoplasm Recurrence, Local | Paclitaxel - adverse effects | Survival Rate | Radiotherapy | Adenocarcinoma - drug therapy | Breast Neoplasms - drug therapy | Disease-Free Survival | Adenocarcinoma - therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - mortality | Aged | Infusions, Intravenous | Receptor, ErbB-2 - analysis | Trastuzumab | Adenocarcinoma - mortality | Breast cancer | Dosage and administration | Drug therapy | Risk factors | Paclitaxel | Invasiveness | Clinical trials | Congestive heart failure | Neuropathy | Cancer therapies | Survival | Patients | ErbB-2 protein | Metastases | Chemotherapy | Epidermal growth factor | Ventricle | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
The lancet oncology, ISSN 1470-2045, 07/2013, Volume 14, Issue 8, pp. 741 - 748
Summary Background Since 2005, 12 months of adjuvant trastuzumab has been the standard treatment for patients with HER2-positive early-stage breast cancer... 
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Breast Neoplasms - surgery | Predictive Value of Tests | Breast Neoplasms - secondary | Receptor, ErbB-2 - genetics | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Antineoplastic Agents - administration & dosage | Protein Kinase Inhibitors - adverse effects | Young Adult | Breast Neoplasms - chemistry | Antibodies, Monoclonal, Humanized - administration & dosage | Neoplasms, Second Primary | Time Factors | Antineoplastic Agents - adverse effects | Aged, 80 and over | Mastectomy | Adult | Female | Chemotherapy, Adjuvant | France | Heart Diseases - chemically induced | Radiotherapy, Adjuvant | Antibodies, Monoclonal, Humanized - adverse effects | Drug Administration Schedule | Early Detection of Cancer | Kaplan-Meier Estimate | Neoplasm Recurrence, Local | Proportional Hazards Models | Treatment Outcome | Breast Neoplasms - drug therapy | Disease-Free Survival | Protein Kinase Inhibitors - administration & dosage | Breast Neoplasms - genetics | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - mortality | Aged | Infusions, Intravenous | Receptor, ErbB-2 - analysis | Trastuzumab | Antimitotic agents | Care and treatment | Clinical trials | Breast cancer | Product development | Antineoplastic agents | Cancer | Index Medicus
Journal Article